High prevalence of asymptomatic malaria in a tribal population in eastern India

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1439-1444

  Ganguly, Swagata ^a   Saha, Pabitra ^a   Guha, Subhasish K ^a   Biswas, Asit ^b   Das, Sonali ^a   Kundu, Pratip K ^a   Maji, Ardhendu K ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^b Government of West Bengal   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; CARRIER PROTEIN; DRUG COMBINATION; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; SULFADOXINE-PYRIMETHAMINE-ARTESUNATE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; ASYMPTOMATIC DISEASE; CHILD; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE CARRIER; DNA POLYMORPHISM; DNA SEQUENCE; DRUG EFFICACY; FEMALE; GENE; HAPLOTYPE; HEALTH PROGRAM; HUMAN; INDIA; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; NONHUMAN; PFCRT GENE; PFMDR1 GENE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING TEST; SENSITIVITY ANALYSIS; ASYMPTOMATIC INFECTIONS; CLASSIFICATION; DRUG COMBINATION; DRUG RESISTANCE; GENETICS; GENOTYPE; MALARIA, FALCIPARUM; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; POPULATION GROUP; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTESUNATE; PLASMODIUM FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; ASYMPTOMATIC INFECTIONS; BASE SEQUENCE; DRUG COMBINATIONS; DRUG RESISTANCE; GENOTYPE; HUMANS; INDIA; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; PREVALENCE; PROTOZOAN PROTEINS; PYRIMETHAMINE; SEQUENCE ANALYSIS, DNA; SULFADOXINE;

EID: 84876761774     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03437-12     Document Type: Article

References (25)

1. Roll Back Malaria Partnership. 2008. Global malaria action plan. http: //www.rollbackmalaria.org/gmap/gmap.pdf.
2. Mabunda S, Aponte JJ, Tiago A, Alonso PA. 2009. A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Malar. J. 8:74. doi:10.1186/1475-2875-8-74.
3. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F. 2008. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malar. J. 7:17. doi:10.1186/1475-2875-7-17.
4. Dal-Bianco MP, Koster KB, Kombila UD, Kun JF, Grobusch MP, Ngoma GM, Matsiequi PB, Supan C, Salazar CL, Missinou MA, Issifou S, Lell B, Kremsner P. 2007. High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Am. J. Trop. Med. Hyg. 77:939-942.
5. Dunyo S, Miligan P, Edwards T, Sutherland C, Targett G, Pinder M. 2006. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin. Trials 1:e20. doi:10.1371/journal.pctr.0010020.
6. Baliraine FN, Afrane YA, Amenya DA, Bonizzoni M, Menge DM, Zhou G, Zhong D, Vardo-Zalik AM, Githeko A, Yan G. 2009. High prevalence of asymptomatic Plasmodium falciparum infections in a highland area of western Kenya: a cohort study. J. Infect. Dis. 200:66-74.
7. Boonma P, Christensen PR, Suwanarusk R, Price RN, Russell B, Lek-Uthai U. 2007. Comparison of molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparum. Malar. J. 6:124. doi:10.1186/1475-2875-6-124.
8. Snounou G. 2002. Genotyping of Plasmodium spp. nested PCR. Methods Mol. Med. 72:103-116.
9. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Lee SJ, Saisung S, Koecharoen K, Nguon C, Day NP, Socheat D, White NJ. 2010. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob. Agents Chemother. 54:2886-2892.
10. Liljander A, Wiklund L, Falk N, Kweku M, Mårtensson A, Felger I, Färnert A. 2009. Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2). Malar. J. 8:78. doi:10.1186/1475-2875-8-78.
11. Ahmed A, Bararia D, Vinayak S, Yameen M, Biswas S, Dev Kumar VA, Ansari MA, Sharma YD. 2004. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxinepyrimethamine resistance. Antimicrob. Agents Chemother. 48:879-889.
12. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana S, Radrianjafy R, Andrianaranjaka V, Randriantsoa T, Rason MA, Tichit M, Rabarijaona LP, Mercereau-Puijalon O, Durand R, Ménard D. 2009. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob. Agents Chemother. 53:4588-4597.
13. Pandya AP, Barkakaty BN, Narasimham MV. 1991. Changing response of Plasmodium falciparum to chloroquine in West Bengal during 1980-1988. J. Commun. Dis. 23:103-108.
14. Krajden S, Panisko DM, Tobe B, Yang J, Keystone JS. 1991. Prolonged infection with Plasmodium falciparum in a semi-immune patient. Trans. R. Soc. Trop. Med. Hyg. 85:731-732.
15. Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G, Walliker D. 1998. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am. J. Trop. Med. Hyg. 59:582-590.
16. Males S, Gaye O, Garcia A. 2008. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children. Clin. Infect. Dis. 46:516-522.
17. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A. 2008. Relation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. Malar. J. 7:193. doi:10 .1186/1475-2875-7-193.
18. Day KP, Marsh K. 1991. Naturally acquired immunity to Plasmodium falciparum. Immunol. Today 12:A68-A71.
19. Djimdé AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV. 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 69: 558-563.
20. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. 1999. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 5:340-343.
21. Grobusch MP, Kremsner PG. 2005. Uncomplicated malaria. Curr. Top. Microbiol. Immunol. 295:83-104.
22. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GA. 2005. Reduction of malaria transmission to Anophele mosquitoes with a six-dose regimen of co-artemether. PLoS Med. 2:e92. doi:10.1371/journal.pmed.0020092.
23. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW. 2006. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J. Infect. Dis. 193:1151-1159.
24. Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ. 2004. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop. Med. Int. Health 9:53-61.
25. Saha P, Guha SK, Das S, Mullick S, Ganguly S, Biswas A, Bera DK, Chattopadhyay G, Das M, Kundu PK, Ray K, Maji AK. 2012. Comparative efficacy of Artemisinin Combination Therapies (ACTs) in P. falciparum malaria and polymorphism of PfATPase6, Pfcrt, Pfdhfr and Pfdhps genes in tea gardens of Jalpaiguri district, India. Antimicrob. Agents Chemother. 56:2511-2517.